ConductScience.org, home

Paper12547827

Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor.

Sun JP and 7 others. J Biol Chem, 2003. Cited by 129 papers, by iCite.

Cite this record

ConductScience Library. Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor. Papers, record 12547827. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12547827

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor.
PubMed
Journal
J Biol Chem
PubMed
Year
2003
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
129
iCite
Relative citation ratio, by iCite
2.67
iCite
Revised in PubMed
2021-02-06
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sun JPJin-Peng
2Fedorov AAAlexander A
3Lee SYSeung-Yub
4Guo XLXiao-Ling
5Shen KKui
6Lawrence DSDavid S
7Almo SCSteven C
8Zhang ZYZhong-Yin

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PhenylalanineMajor topic
Protein Tyrosine PhosphatasesMajor topic
Alkanesulfonic Acids
Binding Sites
Crystallography
Humans
Kinetics
Morpholines
Mutagenesis, Site-Directed
Protein Structure, Secondary
Protein Structure, Tertiary
Protein Tyrosine Phosphatase, Non-Receptor Type 1
Vanadates

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
GM55242NIGMS NIH HHSUnited StatesR01GM055242PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by48

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.

PMIDTitleJournalYearIn PapersSource
42714812Recent advances of dual PROTACs for potential therapeutic applications.Mol Divers2026https://conductscience.org/library/papers/42714812PubMed
39458839Exploring the Antidiabetic Potential of Salvia officinalis Using Network Pharmacology, Molecular Docking and ADME/Drug-Likeness Predictions.Plants (Basel)2024https://conductscience.org/library/papers/39458839PubMed
38768084Development of Novel Phosphonodifluoromethyl-Containing Phosphotyrosine Mimetics and a First-In-Class, Potent, Selective, and Bioavailable Inhibitor of Human CDC14 Phosphatases.J Med Chem2024https://conductscience.org/library/papers/38768084PubMed
37711015Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview.Curr Med Chem2024https://conductscience.org/library/papers/37711015PubMed
36973833Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T-Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy.Angew Chem Int Ed Engl2023https://conductscience.org/library/papers/36973833PubMed
36837781Molecular and Biological Investigation of Isolated Marine Fungal Metabolites as Anticancer Agents: A Multi-Target Approach.Metabolites2023https://conductscience.org/library/papers/36837781PubMed
35303375Pentafluorophosphato-Phenylalanines: Amphiphilic Phosphotyrosine Mimetics Displaying Fluorine-Specific Protein Interactions.Angew Chem Int Ed Engl2022https://conductscience.org/library/papers/35303375PubMed
34677434Dual Targeting of PTP1B and Aldose Reductase with Marine Drug Phosphoeleganin: A Promising Strategy for Treatment of Type 2 Diabetes.Mar Drugs2021https://conductscience.org/library/papers/34677434PubMed
34655403Discovery of inhibitors targeting protein tyrosine phosphatase 1B using a combined virtual screening approach.Mol Divers2022https://conductscience.org/library/papers/34655403PubMed
33571432Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes.Cell2021https://conductscience.org/library/papers/33571432PubMed
33003469Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment.Cancers (Basel)2020https://conductscience.org/library/papers/33003469PubMed
31298844An Isoform-Selective PTP1B Inhibitor Derived from Nitrogen-Atom Augmentation of Radicicol.Biochemistry2019https://conductscience.org/library/papers/31298844PubMed
30979725Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22.J Biol Chem2019https://conductscience.org/library/papers/30979725PubMed
30299094Computational Strategy for Bound State Structure Prediction in Structure-Based Virtual Screening: A Case Study of Protein Tyrosine Phosphatase Receptor Type O Inhibitors.J Chem Inf Model2018https://conductscience.org/library/papers/30299094PubMed
29414924VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition.Molecules2018https://conductscience.org/library/papers/29414924PubMed
28451373Enzyme-triggered compound release using functionalized antimicrobial peptide derivatives.Chem Sci2017https://conductscience.org/library/papers/28451373PubMed
27095436A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.J Neuroinflammation2016https://conductscience.org/library/papers/27095436PubMed
26435211Protein Tyrosine Phosphatases in Hypothalamic Insulin and Leptin Signaling.Trends Pharmacol Sci2015https://conductscience.org/library/papers/26435211PubMed
26057789Structure of human dual-specificity phosphatase 7, a potential cancer drug target.Acta Crystallogr F Struct Biol Commun2015https://conductscience.org/library/papers/26057789PubMed
25081058The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes.Cell Res2014https://conductscience.org/library/papers/25081058PubMed

See all 48 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
LEP3952PubTator's text mininghttps://conductscience.org/library/genes/3952NCBI Gene
PTPN15770PubTator's text mininghttps://conductscience.org/library/genes/5770NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
PDB1N6W

Source PDB

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12547827

GET https://conductscience.org/api/papers/v1/12547827/cited_by?page=2